Early research (Phase 1)Study completedNCT04257617What this trial is testingA Trial of ZL-1201 in Subjects With Advanced CancerWho this might be right forAdvanced Cancer Zai Lab (Shanghai) Co., Ltd. 37
Early research (Phase 1)Study completedNCT00646139What this trial is testingKX2-391 in Treating Patients With Advanced Solid Tumors or Lymphoma That Did Not Respond to TreatmentWho this might be right forLymphomaLymphoproliferative DisorderSmall Intestine Cancer+1 more Roswell Park Cancer Institute 7
Early research (Phase 1)Study completedNCT00004065What this trial is testingChemotherapy in Treating Patients With Refractory Advanced Solid Tumors or Hematologic CancerWho this might be right forBladder CancerBreast CancerColorectal Cancer+9 more Memorial Sloan Kettering Cancer Center
Early research (Phase 1)Study completedNCT00060645What this trial is testingSafety Study of AP23573 in Patients With Advanced, Refractory or Recurrent Malignancies (8669-013)(COMPLETED)Who this might be right forTumorsLymphomaMultiple Myeloma Merck Sharp & Dohme LLC 33
Early research (Phase 1)Study completedNCT01375842What this trial is testingAtezolizumab (an Engineered Anti-Programmed Death-Ligand 1 [PDL1] Antibody) to Evaluate Safety, Tolerability and Pharmacokinetics in Participants With Locally Advanced or Metastatic Solid TumorsWho this might be right forTumorsHematologic Malignancies Genentech, Inc. 661
Testing effectiveness (Phase 2)Ended earlyNCT03648372What this trial is testingTAK-981 in People With Advanced Solid Tumors or Cancers in the Immune SystemWho this might be right forNeoplasmsLymphomaHematologic Neoplasms Takeda 109
Early research (Phase 1)Study completedNCT00749502What this trial is testingMK4827 in Participants With Advanced Solid Tumors or Hematologic Malignancies (MK-4827-001 AM8)Who this might be right forSolid TumorsChronic Lymphocytic LeukemiaT-cell-prolymphocytic Leukemia Tesaro, Inc. 113
Testing effectiveness (Phase 2)Active Not RecruitingNCT06390865What this trial is testingTesting MLN0128 (TAK-228) as Potentially Targeted Treatment in Cancers With TSC1 or TSC2 Genetic Changes (MATCH - Subprotocol M)Who this might be right forAdvanced LymphomaAdvanced Malignant Solid NeoplasmRefractory Lymphoma+2 more National Cancer Institute (NCI) 49
Early research (Phase 1)UnknownNCT05415098What this trial is testingStudy of Safety, Pharmacokinetic and Efficacy of APG-5918 in Advanced Solid Tumors or LymphomasWho this might be right forNasopharyngeal CarcinomaCastrate Resistant Prostate CancerGastric Cancer+6 more Ascentage Pharma Group Inc. 90
Early research (Phase 1)Study completedNCT00275080What this trial is testingVorinostat and Decitabine in Treating Patients With Advanced Solid Tumors or Relapsed or Refractory Non-Hodgkin's Lymphoma, Acute Myeloid Leukemia, Acute Lymphocytic Leukemia, or Chronic Myelogenous LeukemiaWho this might be right forAdult Acute Myeloid Leukemia With 11q23 (MLL) AbnormalitiesAdult Acute Myeloid Leukemia With Inv(16)(p13;q22)Adult Acute Myeloid Leukemia With t(15;17)(q22;q12)+48 more National Cancer Institute (NCI) 80
Testing effectiveness (Phase 2)Active Not RecruitingNCT04439357What this trial is testingTesting Trametinib as a Potential Targeted Treatment in Cancers With GNAQ or GNA11 Genetic Changes (MATCH-Subprotocol S2)Who this might be right forAdvanced LymphomaAdvanced Malignant Solid NeoplasmHematopoietic and Lymphoid Cell Neoplasm+3 more National Cancer Institute (NCI) 4
Testing effectiveness (Phase 2)Study completedNCT02797977What this trial is testingA Phase 1/2 Trial SRA737 in Combination With Gemcitabine and Cisplatin or Gemcitabine Alone in Advanced Cancer SubjectsWho this might be right forAdvanced Solid Tumors Sierra Oncology LLC - a GSK company 153
Testing effectiveness (Phase 2)Study completedNCT02797964What this trial is testingA Phase 1/2 Trial of SRA737 in Subjects With Advanced CancerWho this might be right forAdvanced Solid Tumors or Non-Hodgkin's Lymphoma (NHL) Sierra Oncology LLC - a GSK company 107
Early research (Phase 1)Study completedNCT00004002What this trial is testingPS-341 in Treating Patients With Advanced Solid Tumors or LymphomaWho this might be right forLymphomaSmall Intestine CancerUnspecified Adult Solid Tumor, Protocol Specific NYU Langone Health
Testing effectiveness (Phase 2)Looking for participantsNCT07410494What this trial is testingBiomarker-Guided Allogeneic Single-Target or Dual-Target CAR-NK Cell Therapy for Advanced Solid TumorsWho this might be right forCancerBreast CancerNon-Small Cell Lung Cancer (NSCLC)+10 more Essen Biotech 85
Early research (Phase 1)Study completedNCT00562380What this trial is testingAMG-479 in Treating Patients With Advanced Solid Tumors or Non-Hodgkin LymphomaWho this might be right forLymphomaProstate CancerSarcoma+2 more Amgen 64
Early research (Phase 1)UnknownNCT04523285What this trial is testingA Phase I Study of TQB728 Tablets on Tolerance and PharmacokineticsWho this might be right forAdvanced Solid Tumor or Hematologic Tumor Chia Tai Tianqing Pharmaceutical Group Co., Ltd. 40
Early research (Phase 1)Ended earlyNCT00019708What this trial is testingGeldanamycin Analogue in Treating Patients With Advanced Solid Tumors or Non-Hodgkin's LymphomaWho this might be right forExtranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid TissueNodal Marginal Zone B-cell LymphomaNon-Hodgkin Lymphoma+25 more National Cancer Institute (NCI) 45
Early research (Phase 1)Study completedNCT00734890What this trial is testingVandetanib and Bevacizumab in Treating Patients With Advanced Solid Tumors or LymphomaWho this might be right forLung CancerLymphomaLymphoproliferative Disorder+2 more National Institutes of Health Clinical Center (CC) 18
Early research (Phase 1)Study completedNCT00025129What this trial is testingVNP40101M in Treating Patients With Advanced Solid Tumors or LymphomasWho this might be right forLymphomaSmall Intestine CancerUnspecified Adult Solid Tumor, Protocol Specific Vion Pharmaceuticals